A population-based study of large granular lymphocyte leukemia

Area of Science:

• Hematology
• Oncology

Background:

• Large granular lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder involving cytotoxic T-cells.
• Characterized by T-cell accumulation in blood and organ infiltration, its population-based incidence and survival data are limited.

Purpose of the Study:

• To define the clinical characteristics, natural history, and survival predictors of LGL leukemia.
• To analyze incidence and risk factors for poor prognosis using large national databases.

Main Methods:

• Utilized the Surveillance, Epidemiology, and End Results (SEER) Program and the National Cancer Data Base (NCDB).
• Analyzed patient-level data (n=978) for clinical features, treatment patterns, and survival outcomes.
• Performed multivariate analysis to identify independent predictors of poor survival.

Main Results:

• LGL leukemia incidence is extremely low (0.2 per 1,000,000 individuals).
• Median age at diagnosis is 66.5 years; females diagnosed ~3 years earlier than males.
• Median overall survival is 9 years; 45% of T-LGL leukemia patients required systemic treatment at diagnosis.

Conclusions:

• Age over 60 and significant comorbidities are independent predictors of poor survival in LGL leukemia.
• T-LGL leukemia patients experience reduced survival compared to the general population.
• This study provides crucial population-based insights into LGL leukemia's epidemiology and prognosis.